THR-beta Agonists Market
(0 User reviews)
150
72
Abstract
According to the Market Statsville Group (MSG), the Global THR-β Agonists Market size is expected to grow at a CAGR of 5.3% from 2023 to 2033.
β2 agonists are a class of drugs that selectively activate β2 adrenergic receptors. These receptors are found in the muscles of the respiratory tract and blood vessels, and manages the regulation of bronchodilation and vasodilation. Activation of β2 receptors leads to relaxation of smooth muscles, resulting in widened airways and increased blood flow to specific areas of the body. β2 agonists are used for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
THR-beta Agonists Market
According to the Market Statsville Group (MSG), the Global THR-β Agonists Market size is expected to grow at a CAGR of 5.3% from 2023 to 2033.
β2 agonists are a class of drugs that selectively activate β2 adrenergic receptors. These receptors are found in the muscles of the respiratory tract and blood vessels, and manages the regulation of bronchodilation and vasodilation. Activation of β2 receptors leads to relaxation of smooth muscles, resulting in widened airways and increased blood flow to specific areas of the body. β2 agonists are used for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
There are no reviews for this Book.
There are no comments for this Book.
You must log in to post a comment.
Log in
